A Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients with High-Risk Castrate, Biochemically Relapsed Prostate Cancer

Abstract

Clinical trial has received WCMC IRB and CTSC approval with enrollment of initial 5 subjects at WCMC. An additional 33 subjects enrolled (28 treated) at participating sub-sites. Reports submitted to WCMC DSMB in July 2014 with approval to proceed without modifications.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2014
Accession Number
ADA621020

Entities

People

  • Scott T Tagawa

Organizations

  • Cornell University

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Chemistry
  • Diagnostic Imaging
  • Embolism And Thrombosis
  • Health Services
  • Hematologic Diseases
  • Medical Personnel
  • Oncology
  • Photoacoustic Tomography
  • Proteins

Readers

  • Clinical Trial Research.